Scientific Name: Axitinib
Brand Name: Inlyta
Company Owner: Not Available
Mechanism Of Action Axitinib selectively blocks the tyrosine kinase receptors VEGFR-1 (vascular endothelial growth factor receptor) , VEGFR-2, and VEGFR-3.
Description of the Drug: Axitinib is an oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from